Anandamide inhibits endothelin-1 production by human cultured endothelial cells: A new vascular action of this endocannabinoid

Pharmacology

Volumn 79, Issue 1, 2007, Pages 12-16

  Ronco, Ana María ^a   Llanos, Miguel ^a   Tamayo, Daniela ^a   Hirsch, Sandra ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Anandamide; Endothelial cells; Endothelin 1; Nitric oxide; SR 141716A

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; ENDOTHELIN 1; NITRIC OXIDE; RIMONABANT;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; VASODILATATION;

ADENINE; ADENOSINE; ARACHIDONIC ACIDS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NITRIC OXIDE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; XANTHINES;

EID: 33845951973     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097072     Document Type: Article

References (28)

1. McGorisk G, Treasure C: Endothelial dysfunction in coronary heart disease. Curr Opin Cardiol 1996;11:341-350.
2. De Caterina R: Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Clin Nutr Metab Care 2000;3:453-467.
3. Randall M, Alexander S, Bennet T, Boyd E, Fry J, Gardiner S, Kemp P, McCulloch A, Kendall D: An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 1996;229:114-120.
4. Munro S, Thomas K, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-65.
5. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM, Liu J, Kunos G: Evidence for novel cannabinoid receptors. Pharmacol Ther 2005;106:133-145.
6. Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K: Detection of an endogenous cannabimimetic molecule, 2-arachidonoyl glycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 1998;243:838-843.
7. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, Kunos G: Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 2000;346:835-840.
8. Harris D, Mcculloch A, Kendall D, Randall M: Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J Physiol 2002;539:893-902.
9. Chataigneau T, Feletou M, Thollon C, Villenueve N, Vilaine J, Duhault J, Vanhoutte P: Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol 1998;123:968-974.
10. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 1993;61:352-355.
11. Mackie K, Hille B: Cannabinoids inhibit N-type calcium channels in neuroblastomaglioma cells. Proc Natl Acad Sci USA 1992;89:3825-3829.
12. Deutsch D, Goligorsky M, Schmid P, Krebsbach R, Schmid H, Das S, Dey S, Arreaza G, Thorup C, Stefanot G, Moore L: Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 1997;100:1538-1546.
13. 1 receptors. Life Sci 2005;76:1307-1324.
14. 1 receptor. Br J Pharmacol 2003;140:1451-1459.
15. Pelletier S, Battistini B, Sirois P: Adenosine-induced inhibition of basal endothelin-1 production from guinea-pig tracheal epithelial cells: a mechanism involving the release of cAMP. Pulm Pharmacol Ther 1998;11:237-242.
16. Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T, Biaggioni I: Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ Res 2002;90:531-538.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
18. Demuth K, Atger V, Borderie D, Benoit MO, Sauvaget D, Lotersztajn S, Moatti N: Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem 1999;263:367-376.
19. Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, Finazzi-Agro A: Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J Biol Chem 2000;275:13484-13492.
20. Misko T, Schilling R, Salvemini D, Moore W, Currie M: A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-16.
21. Nakas-Icindic E, Zaciragic A, Hadzovic A, Avdagic N: Endothelin in health and disease. Bosn J Basic Med Sci 2004;4:31-34.
22. Galley HF, Webster NR: Physiology of the endothelium. Br J Anaesth 2004;93:105-113.
23. Sala C, Monopoli A, Alberti C, Casati C, Ongini E, Zanchetti A, Morganti A: Humoral effects of selective adenosine agonists in spontaneously hypertensive rats. J Hypertens 1996;14:75-79.
24. Wagner JA, Varga K, Jarai Z, Kunos G: Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 1999;33:429-434.
25. Mukhopadhyay S, Chapnick BM, Howlett AC: Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol 2002;282:H2046-H2054.
26. Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M: Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res 2004;132:87-92.
27. Pertwee RG: Novel pharmacological targets for cannabinoids. Curr Neuropharmacol 2004;2:9-29.
28. Wort SJ, Mitchell JA, Woods M, Evans TW, Warner TD: The prostacyclin mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol 2000;36(suppl 1):s410-s413.